EAM Investors’s Coherus Oncology CHRS Stock Holding History

EAM Investors’s Portfolio CHRS Stock Details CHRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$524K	Buy
2019 Q3	–	Sell
2019 Q2	$1.46M	Buy
2017 Q1	–	Sell
2016 Q4	$694K	Sell
2016 Q3	$1.03M	Buy
2015 Q4	–	Sell
2015 Q3	$715K	Buy
2015 Q2	–	Sell
2015 Q1	$4.97M	Buy